Michael Pfeilstöcker
Michael Pfeilstöcker publishes mostly in Hematology, Genetics and Molecular Biology, on topics such as Acute Myeloid Leukemia Research, Myeloproliferative Neoplasms: Diagnosis and Treatment and Chronic Myeloid Leukemia Treatments.
- World rank
- #1,508,846 of 7,710,434 ranked researchers
- Rank in Austria
- #9,117 of 43,330
- Works
- 183
- Citations
- 9k
- Citations per work
- 49.0
What does Michael Pfeilstöcker research?
Michael Pfeilstöcker's work is mostly in Medicine (64%), Biochemistry, Genetics and Molecular Biology (9%), Immunology and Microbiology (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences11764.2%
- Medicine11764.2%
- Everything else4122.5%
- Life Sciences2413.3%
- 1Hematology37% of their works
- 2Genetics18% of their works
- 3Molecular Biology9% of their works
- 4Oncology6% of their works
- 5Immunology4% of their works
- 6Pathology and Forensic Medicine4% of their works
Research topics
- Acute Myeloid Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Chronic Myeloid Leukemia Treatments
- Chronic Lymphocytic Leukemia Research
- Lymphoma Diagnosis and Treatment
- Retinoids in leukemia and cellular processes
- Acute Lymphoblastic Leukemia research
- Multiple Myeloma Research and Treatments
Which keywords describe Michael Pfeilstöcker's research?
The keywords of their largest research topics: Prognostic Factors, Acute Myeloid Leukemia, AML, JAK2 Mutation, Myelofibrosis, Rituximab, Minimal Residual Disease and BCR-ABL.
- Diagnosis Criteria
- Childhood Cancer
- Acute Lymphoblastic Leukemia
- Classification
- Chronic Lymphocytic Leukemia
- BCR-ABL
- Rituximab
- JAK2 Mutation
- AML
- Prognostic Factors
- Acute Myeloid Leukemia
- Myelofibrosis
- Minimal Residual Disease
- Imatinib
- Genomic Aberrations
- Lymphoma
- Acute Promyelocytic Leukemia
- Retinoic Acid
- International Myeloma Working Group
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 19 words, with their numbers
- Prognostic Factors1753 topics
- AML1381 topic
- Acute Myeloid Leukemia1381 topic
- JAK2 Mutation581 topic
- Myelofibrosis581 topic
- Rituximab382 topics
- Minimal Residual Disease302 topics
- BCR-ABL261 topic
- Imatinib261 topic
- Chronic Lymphocytic Leukemia211 topic
- Genomic Aberrations211 topic
- Classification171 topic
- Lymphoma171 topic
- Acute Lymphoblastic Leukemia161 topic
- Acute Promyelocytic Leukemia161 topic
- Childhood Cancer161 topic
- Retinoic Acid161 topic
- Diagnosis Criteria141 topic
- International Myeloma Working Group141 topic
Where does Michael Pfeilstöcker work?
Michael Pfeilstöcker's main affiliation in the publication record is Hanusch Hospital, Austria.
How many publications and citations does Michael Pfeilstöcker have?
OpenAlex counts 183 works and 8,972 citations for Michael Pfeilstöcker, an h-index of 35, ranking #1,508,846 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Michael Pfeilstöcker. Posts are plain text and can be reported.